DiaMedica Therapeutics Inc (NAS:DMAC)
$ 3.12 -0.13 (-4%) Market Cap: 118.43 Mil Enterprise Value: 65.93 Mil PE Ratio: 0 PB Ratio: 2.32 GF Score: 40/100

DiaMedica Therapeutics Inc (DMAC) Stock Estimates Data

DiaMedica Therapeutics Inc (DMAC) 12 Month Price Targets

DiaMedica Therapeutics Inc (DMAC) Analyst Rating